Nazwa produktu: |
oxendolone |
Angielska nazwa |
oxendolone; Oxendolone [USAN:INN:JAN]; Tsaa 291; 16-Ethyl-17-hydroxyester-4-en-3-one; 16-beta-Ethyl-17-beta-hydroxyestr-4-en-3-one; 16-beta-Ethyl-19-nortestosterone; 16beta-Ethyl-17beta-hydroxyestr-4-en-3-one; Oxendolona; Oxendolona [INN-Spanish]; Oxendolonum; Oxendolonum [INN-Latin]; Prostetin; UNII-MN4I850D4P; (16beta,17beta)-16-Ethyl-17-hydroxyestr-4-en-3-one; Estr-4-en-3-one, 16-beta-ethyl-17-beta-hydroxy-; Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16-beta,17-beta)- (9CI); Estr-4-en-3-one, 16-ethyl-17-hydroxy-, (16beta,17beta)-; (8xi,10xi,13xi,17beta)-16-ethyl-17-hydroxyestr-4-en-3-one |
MF |
C20H30O2 |
Masie cząsteczkowej |
302.451 |
InChI |
InChI=1/C20H30O2/c1-3-12-11-18-17-6-4-13-10-14(21)5-7-15(13)16(17)8-9-20(18,2)19(12)22/h10,12,15-19,22H,3-9,11H2,1-2H3/t12-,15-,16+,17+,18-,19-,20-/m0/s1 |
Nr CAS |
33765-68-3 |
Struktury molekularnej |
|
Gęstość |
1.1g/cm3 |
Temperatura wrzenia |
451.7°C at 760 mmHg |
Współczynnik załamania |
1.553 |
Temperatura zapłonu |
192.4°C |
Ciśnienie pary |
4.66E-10mmHg at 25°C |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|